Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Medirebi IT 20mg/150mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Medios Laboratories Pvt Ltd

Salt Composition

Rabeprazole (20mg) + Itopride (150mg)

Overview Medirebi IT 20mg/150mg Capsule SR

Gastroesophageal reflux disease (GERD) and peptic ulcers are effectively managed with the combination medication, Medirebi IT 20mg/150mg SR Capsules. This formulation alleviates common acidity symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Medirebi IT 20mg/150mg SR Capsules should strictly adhere to your physician's instructions, varying based on individual response and condition severity. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is essential due to potential interactions. Common, generally transient, side effects include stomach pain, diarrhea, constipation, headache, gas, fatigue, and increased salivation. Report any concerning side effects immediately. Drowsiness and dizziness are possible; refrain from driving or mentally demanding tasks until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and omitting hot beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any liver conditions, pregnancy, pregnancy planning, or breastfeeding to your doctor.

Primary Ingredients of Medirebi IT 20mg/150mg Capsule SR

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Medirebi IT 20mg/150mg Capsule SR

Heartburn and ulcers stemming from stomach acid

Major Benefits of Medirebi IT 20mg/150mg Capsule SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire capsule without crushing, chewing, or breaking it. Medirebi IT 20mg/150mg Extended-Release Capsules should be taken on an empty stomach.

Common Side effects of Medirebi IT 20mg/150mg Capsule SR:

  • Stomach pain
  • Diarrhea
  • Constipation
  • Headache
  • Dizziness
  • Flatulence
  • Weakness
  • Flu-like symptoms
  • Increased saliva production

How to use Medirebi IT 20mg/150mg Capsule SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer Medirebi IT 20mg/150mg Sustained-Release Capsules on an empty stomach.

How Medirebi IT 20mg/150mg Capsule SR works:

Medirebi IT Capsules SR, containing 20mg rabeprazole and 150mg itopride, offer dual action against acid reflux and digestive discomfort. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, alleviating heartburn and indigestion. Itopride, a prokinetic agent, targets brain centers regulating nausea and enhances upper gastrointestinal motility, facilitating smoother food passage.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when drinking alcohol while taking Medirebi IT 20mg/150mg sustained-release capsules. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Medirebi IT 20mg/150mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Medirebi IT 20mg/150mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Medirebi IT 20mg/150mg SR capsules can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Medirebi IT 20mg/150mg sustained-release capsules in individuals with renal impairment. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Medirebi IT 20mg/150mg sustained-release capsules. Dosage modification of Medirebi IT 20mg/150mg sustained-release capsules may be necessary. Physician consultation is advised.

What if you forget to take Medirebi IT 20mg/150mg Capsule SR :

Should you forget a dose of Medirebi IT 20mg/150mg SR Capsules, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Medirebi IT 20mg/150mg Capsule SR

LabelValue
Developing Habits No.
Treatment Category Gastrointestinal system
Medirebi IT 20mg/150mg Ca...
96
MRP 117
17% off